Member-only story

Testing New Drugs On The World Poorest Patients: An Exposé of the Global Pharmaceutical Industry

Fletcher Mitchell

·2.7k Followers· Follow

Published in The Body Hunters: Testing New Drugs On The World S Poorest Patients

5 min read · 4 weeks before

382 View Claps

20 Respond

Save

Listen

In 2005, a group of doctors and researchers published a report in the journal The Lancet that exposed the shocking practices of the global pharmaceutical industry. The report, titled "Testing New Drugs on the World's Poorest Patients," revealed that pharmaceutical companies were routinely testing their new drugs on patients in developing countries who were often unaware of the risks involved.

The Body Hunters: Testing New Drugs on the World's Poorest Patients

by Sonia Shah

4.5 out of 5

Language	:	English
File size	:	894 KB
Text-to-Speech	:	Enabled
Screen Reader	:	Supported
Enhanced typesetting	:	Enabled
Print length	:	257 pages

The report found that these patients were often given drugs that had not been approved by their own governments and that they were not given adequate information about the potential side effects.

In some cases, the patients were given drugs that were still in the early stages of development and had not been proven to be safe or effective. In other cases, the patients were given drugs that were known to have serious side effects, but the doctors and researchers did not tell them about these risks.

The report's authors concluded that the pharmaceutical industry was exploiting the world's poorest patients in Free Download to make a profit. They called on the industry to stop testing new drugs on these patients and to invest more in research and development that would benefit all patients.

The Pharmaceutical Industry's Response

The pharmaceutical industry responded to the report by saying that it was committed to the safety of its patients and that it only tested new drugs on people who were fully informed about the risks involved.

However, the industry's own documents show that this is not always the case. In 2010, a group of researchers published a study in the journal PLoS Medicine that found that pharmaceutical companies were often not providing patients with adequate informed consent before they enrolled them in clinical trials.

The study also found that pharmaceutical companies were often not disclosing the full results of their clinical trials to the public. In many cases, the companies were only reporting the positive results of their trials and hiding the negative results.

The Impact of Drug Testing on the World's Poorest Patients

The testing of new drugs on the world's poorest patients has had a devastating impact on their health. In some cases, patients have died from the side effects of the drugs they were given. In other cases, patients have been left with permanent disabilities.

The testing of new drugs on the world's poorest patients has also eroded trust in the pharmaceutical industry. Patients have lost faith in the industry's ability to protect their health and well-being.

The Way Forward

The pharmaceutical industry needs to change its ways. It needs to stop testing new drugs on the world's poorest patients and it needs to invest more in research and development that will benefit all patients.

Governments also need to do more to protect their citizens from the harmful practices of the pharmaceutical industry. They need to pass laws that require pharmaceutical companies to provide patients with adequate informed consent before they enroll them in clinical trials.

They also need to require pharmaceutical companies to disclose the full results of their clinical trials to the public. By taking these steps, governments can help to ensure that the world's poorest patients are not exploited by the pharmaceutical industry.